|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Operating activities: | |||||
| Net income (loss) | |||||
| Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities: | |||||
| Amortization of deferred financing costs | |||||
| Accretion of discounts, deferred loan origination fees and costs | |||||
| Stock-based compensation | |||||
| Depreciation and amortization of real estate owned | |||||
| Provision for (reversal of) current expected credit losses, net | |||||
| Realized losses on loans | |||||
| Change in unrealized losses on loans held for sale | |||||
| Amortization of derivative financial instruments | |||||
| Realized (gain) loss on sale of real estate owned | |||||
| Changes in operating assets and liabilities: | |||||
| Other assets | |||||
| Due to affiliate | |||||
| Other liabilities | |||||
| Net cash provided by (used in) operating activities | |||||
| Investing activities: | |||||
| Issuance of and fundings on loans held for investment | |||||
| Principal collections and cost-recovery proceeds on loans held for investment | |||||
| Proceeds from sale of loans held for sale | |||||
| Receipt of origination and other loan fees | |||||
| Purchases of available-for-sale debt securities | |||||
| Principal repayment of available-for-sale debt securities | |||||
| Purchases of capitalized additions to real estate owned | |||||
| Proceeds from sale of real estate owned | |||||
| Restricted cash assumed from acquisition of real estate owned | |||||
| Amounts received (paid) under derivative financial instruments | |||||
| Receipt (disbursement) of escrows and reserves for loans held for investment, net | |||||
| Net cash provided by (used in) investing activities | |||||
| Financing activities: | |||||
| Proceeds from secured funding agreements | |||||
| Secured funding agreements | |||||
| Secured term loan | |||||
| Repayments of secured funding agreements | |||||
| Secured funding agreements | |||||
| Secured bowowings | |||||
| Secured term loan | |||||
| Proceeds from notes payable | |||||
| Repayments of notes payable | |||||
| Payment of secured funding costs | |||||
| Proceeds from issuance of debt of consolidated VIEs | |||||
| Repayments of debt of consolidated VIEs | |||||
| Dividends paid | |||||
| Proceeds from sale of common stock | |||||
| Repurchase of common stock | |||||
| Payment of offering costs | |||||
| Net cash provided by (used in) financing activities | |||||
| Change in cash, cash equivalents and restricted cash | |||||
| Cash, cash equivalents and restricted cash, beginning of period | |||||
| Cash, cash equivalents and restricted cash, end of period | |||||
| Supplemental Information: | |||||
| Interest paid during the period | |||||
| Income taxes paid during the period | |||||
| Supplemental disclosure of noncash investing and financing activities: | |||||
| Dividends declared, but not yet paid | |||||
| Other receivables related to consolidated VIEs | |||||
| Assumption of real estate owned | |||||
| Assumption of other assets related to real estate owned | |||||
| Assumption of other liabilities related to real estate owned | |||||
| Transfer of senior mortgage loans to real estate owned | |||||
| Reconciliation of cash, cash equivalents and restricted cash: | |||||
| Cash and cash equivalents | |||||
| Restricted cash | |||||
Loading...